Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Free Cash Flow (2024 - 2025)

Caris Life Sciences has reported Free Cash Flow over the past 2 years, most recently at $53.5 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $53.5 million for Q4 2025, up 253.66% from a year ago — trailing twelve months through Dec 2025 was $74.0 million (changed N/A YoY), and the annual figure for FY2025 was $80.7 million, up 132.64%.
  • Free Cash Flow for Q4 2025 was $53.5 million at Caris Life Sciences, down from $55.3 million in the prior quarter.
  • Over the last five years, Free Cash Flow for CAI hit a ceiling of $55.3 million in Q3 2025 and a floor of -$71.3 million in Q3 2024.